| 000 | 01607 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514015054.0 | ||
| 264 | 0 | _c20020125 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a1090-9508 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoss, L | |
| 245 | 0 | 0 |
_aThymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens. _h[electronic resource] |
| 260 |
_bJournal of human virology _c |
||
| 300 |
_a217-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Viral _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aStavudine _xpharmacology |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aViremia _xdrug therapy |
| 650 | 0 | 4 |
_aZidovudine _xpharmacology |
| 700 | 1 | _aHenry, K | |
| 700 | 1 | _aPaar, D | |
| 700 | 1 | _aSalvato, P | |
| 700 | 1 | _aShaefer, M | |
| 700 | 1 | _aFisher, R | |
| 700 | 1 | _aLiao, Q | |
| 700 | 1 | _aSt Clair, M | |
| 773 | 0 |
_tJournal of human virology _gvol. 4 _gno. 4 _gp. 217-22 |
|
| 999 |
_c11610446 _d11610446 |
||